The current medicine chest for treating COVID-19 is fairly sparse.Only one drugremdesiviris approved by the U.S. Food and Drug Administration (FDA), and threePaxlovid, molnupiravir, and convalescent plasmahave emergency use authorization from the FDA.With new variants of the virus continuing to emerge, developing next-generation treatments is a top priority.
#people #possibility #potentially #researchers #combination #federal-government #participants #consideration #highest-level #authorization
[
add
]
[
|
|
...
]